For example, the silencing of miR-9-3a tumor suppressor miRNA by methylation may account for the constitutive upregulation of NFKB1, and hence the constitutive activation of NF-κB in CLL patients [19]. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.